Correlation Between Cytokinetics and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cytokinetics and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytokinetics and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cytokinetics and Akero Therapeutics, you can compare the effects of market volatilities on Cytokinetics and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytokinetics with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytokinetics and Akero Therapeutics.
Diversification Opportunities for Cytokinetics and Akero Therapeutics
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cytokinetics and Akero is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Cytokinetics and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Cytokinetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytokinetics are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Cytokinetics i.e., Cytokinetics and Akero Therapeutics go up and down completely randomly.
Pair Corralation between Cytokinetics and Akero Therapeutics
Given the investment horizon of 90 days Cytokinetics is expected to generate 130.26 times less return on investment than Akero Therapeutics. But when comparing it to its historical volatility, Cytokinetics is 1.24 times less risky than Akero Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Akero Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 2,869 in Akero Therapeutics on August 29, 2024 and sell it today you would earn a total of 247.00 from holding Akero Therapeutics or generate 8.61% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cytokinetics vs. Akero Therapeutics
Performance |
| Timeline |
| Cytokinetics |
| Akero Therapeutics |
Cytokinetics and Akero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cytokinetics and Akero Therapeutics
The main advantage of trading using opposite Cytokinetics and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytokinetics position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.| Cytokinetics vs. Edgewise Therapeutics | Cytokinetics vs. Dyne Therapeutics | Cytokinetics vs. Stoke Therapeutics | Cytokinetics vs. Pliant Therapeutics |
| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |